About Index Trending news
Analyze
Pricing
Zosano Pharma

Zosano Pharma

Zosano Pharma

Zosano Pharma, a biopharmaceutical company, develops products based on thetransdermal delivery technology.

Elsewhere

Alexa global traffic share

29 Aug 2016
$7,540,000
Post-IPO equity

SEC FORM D

sec
03 Feb 2015
$14,999,996
Post-IPO equity
04 Dec 2014
$1,333,000
Debt financing
19 Sep 2013
$3,030,000
Debt financing
NEA, BioMed Ventures, Nomura International
06 Aug 2009
$30,000,000
Venture capital (Series B)
NEA, ProQuest Investments, HBM BioVentures, +1
15 Nov 2007
$90,000,000
Venture capital (Series A)
NEA, ProQuest Investments, HBM BioVentures, +1